23.06.2023 • News

Enzene Biosciences Plans Biopharma Campus in USA

Indian CDMO Enzene Biosciences — a subsidiary of Alkem Laboratories — is to build a biopharmaceutical manufacturing plant on the Princeton West Innovation Campus in Hopewell, New Jersey, USA.

© Gary L Hider - stock.adobe.com
© Gary L Hider - stock.adobe.com

The facility will be Enzene’s first outside of India when it starts up in June 2024, initially employing 50 staff and expanding to 300 in the future.

Enzene said the New Jersey manufacturing capabilities will provide North American biopharmaceutical companies with streamlined supply chains, fast turnaround times, enhanced communication and greater control over the manufacturing process.

Located in Pune, Enzene is focused on producing biosimilars, novel biologics, synthetic peptides and phytopharmaceuticals.

Author: Elaine Burridge, Freelance Journalist

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read